NCT06044779

TAP vs. ESP Block for Gynecological Post Operative Pain

Transversus Abdominis Plane (TAP) Block and Erector Spinae Plane (ESP) Block Comparison on Postoperative Pain and the Need for Morphine in Gynecological Surgery Patients Who Underwent Median Incision in Hasan Sadikin General Hospital

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 40 (actual)
• Sponsor: Universitas Padjadjaran · Academic / Other
• Sex: Female
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The goal of this double blind randomized controlled trial is to compare transversus abdominis plane block and erector spinae plane block in gynecological surgery patients. The main questions it aims to answer are: * What are the numerical post-operative pain scores in these two groups? * Is there any significant difference in the numerical post-operative pain scores between subjects who underwent TAP block and subjects who underwent ESP block? * What are the differences in the time needed for additional morphine in these two groups? * Is there any significant differences in the time needed for additional morphine between subjects who underwent TAP block and subjects who underwent ESP block?

Conditions

• Nerve Block
• Pain, Postoperative

Interventions

Type	Name	Description
PROCEDURE	Transversus Abdominis Plane Block using 0.25% Bupivacaine	TAP block regional anesthesia with ultrasound guidance with administration of 20 mL of 0.25% Bupivacaine in the abdominal wall before the operation is completed. The patient was also fitted with a morphine PCA device with a background dose of 5 µg/kgBW/hour and a rescue dose of 1 mg with a lockout interval of 10 minutes.
PROCEDURE	Erector Spinae Plane Block using 0.25% Bupivacaine	Regional anesthesia ESP block under ultrasound guidance with 20 mL of 0.25% bupivacaine at the tip of the transverse process at the T9 level before completion of surgery. The patient was also fitted with a morphine PCA device with a background dose of 5 µg/kgBW/hour and a rescue dose of 1 mg with a lockout interval of 10 minutes.

Timeline

• Start date: 2022-12-27
• Primary completion: 2023-03-26
• Completion: 2023-03-26
• First posted: 2023-09-21
• Last updated: 2023-09-22

Locations

1 site across 1 country: Indonesia